The importance of frailty codes …
QOF 2019/20 has had it’s most significant review since 2004. In the past, universal targets have been set which can lead to under-treatment for those with less complex needs and over-treatment for those with more complex needs. A one-size fits all approach doesn’t always work.
DM019 - % patients with diabetes without moderate/severe frailty in whom last BP (measured preceding 12 months) is 140/80 mmHg or less.
DM020 - % patients with diabetes without moderate/severe frailty in whom last IFCC-HbA1c (measured preceding 12 months) is 58 mmol/mol or less
DM021 - % patients with diabetes with moderate/severe frailty in whom last IFCC-HbA1c (measured preceding 12 months) is 75 mmol/mol or less
DM022 - % patients with diabetes aged 40+ with no history of CVD without moderate/severe frailty currently treated with a statin (exc patients with type2 diabetes & CVD risk score <10% recorded preceding 3 years)
The targets for patients without moderate/severe frailty are harder to achieve - patients with moderate/ severe frailty have limited daily activities, they lead a much more sedentary lifestyle and over-medicating can lead to more complications. Therefore, it is essential you record patient’s frailty to ensure you are achieving the most appropriate target for the patient -
INSIGHT MEMBERS - many clinical system resources available on the members portal for frailty including data entry templates, protocols and searches